These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The INN crowd. Nat Biotechnol; 2013 Dec; 31(12):1055. PubMed ID: 24316620 [No Abstract] [Full Text] [Related]
4. A divided INN crowd. Greenwood J Nat Biotechnol; 2014 Feb; 32(2):131-2. PubMed ID: 24509753 [No Abstract] [Full Text] [Related]
5. A divided INN crowd. Eich G Nat Biotechnol; 2014 Feb; 32(2):131. PubMed ID: 24509754 [No Abstract] [Full Text] [Related]
6. A divided INN crowd. Schellekens H Nat Biotechnol; 2014 Feb; 32(2):132. PubMed ID: 24509755 [No Abstract] [Full Text] [Related]
7. A divided INN crowd. Chin WW Nat Biotechnol; 2014 Feb; 32(2):130. PubMed ID: 24509752 [No Abstract] [Full Text] [Related]
8. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century. Kweder SL Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917 [No Abstract] [Full Text] [Related]
9. New countermeasures considered as drug counterfeiting grows. Schubert C Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355 [No Abstract] [Full Text] [Related]
10. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
11. [Generic prescription should be evaluated as new way of prescription in Denmark]. Hellebek A; Søndergaaard J; Thirstrup S; Sales Y Ugeskr Laeger; 2012 Aug; 174(35):1974. PubMed ID: 22929572 [No Abstract] [Full Text] [Related]
12. Proposed US Food and Drug Administration guidance for industry on distributing medical publications about the risks of prescription drugs and biological products: a misguided approach. Wolfe SM JAMA Intern Med; 2014 Oct; 174(10):1543-4. PubMed ID: 25127222 [No Abstract] [Full Text] [Related]
13. Deterring the importation of counterfeit pharmaceutical products. Stearn DW Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351 [No Abstract] [Full Text] [Related]
15. What's in a (drug) name? Plenty! Mitka M JAMA; 1999 Oct; 282(15):1409-10. PubMed ID: 10535417 [No Abstract] [Full Text] [Related]
16. A survey of top 200 drugs--inconsistent practice of drug strength expression for drugs containing salt forms. Prohotsky DL; Zhao F J Pharm Sci; 2012 Jan; 101(1):1-6. PubMed ID: 21905029 [TBL] [Abstract][Full Text] [Related]
17. Dora Akunyili: battling against counterfeit drugs. Interview by Marilynn Larkin. Akunyili D Lancet Infect Dis; 2006 Sep; 6(9):554-5. PubMed ID: 16931405 [No Abstract] [Full Text] [Related]
18. Use caution when donating drugs, guidelines suggest. Riggs B CMAJ; 1990 Jan; 142(1):65-6. PubMed ID: 2293855 [No Abstract] [Full Text] [Related]
19. What's in a name? Generics and the persistence of the pharmaceutical brand in American medicine. Greene JA J Hist Med Allied Sci; 2011 Oct; 66(4):468-506. PubMed ID: 20858701 [TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals and medical devices: business practices. ; Steiner DJ Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396 [No Abstract] [Full Text] [Related] [Next] [New Search]